14.02.2018 • News

Restricted Chemicals Found in Consumer Products

An inspection by the ECHA has found hundreds of consumer products containing...
An inspection by the ECHA has found hundreds of consumer products containing chemicals that are restricted under REACH legislation

An inspection by the European Chemicals Agency (ECHA) has found hundreds of consumer products containing chemicals that are restricted under REACH legislation. The investigation by ECHA's enforcement forum in 2016 discovered phthalates, cadmium and asbestos, all of which are highly restricted under REACH’s Annex XIV rule and prohibited without specific authorization.

The agency said that out of 5,625 product checks, 18% did not comply with the restrictions. The most frequent breaches were phthalates in toys, with 20% of those inspected containing bis(2-ethylhexyl) (DEHP), dibutyl phthalate (DBP) or benzyl butyl phthalate (BBP) at levels above those permitted.

In addition, cadmium was found in 14% of brazing fillers, and asbestos fibers were discovered in 14% of the products tested, including catalytic heaters, thermos flasks and brake pads.  However, the agency noted that the products containing asbestos were mostly second-hand and likely produced before the restrictions came into force.

Inspectors also found high concentrations of chromium VI in leather articles (13%), cadmium in jewelry (12%) and polycyclic aromatic hydrocarbons (8%) in (undisclosed) products.  In addition, there was an 88.5 % non-compliance rate in the 392 product checks for measuring devices, most of which contained mercury above the legal limit.

ECHA said the report highlighted companies’ responsibility to get information on the chemical composition of their products from suppliers. The authority said it will continue to enforce REACH restrictions by analyzing further products on the market.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read